FASLG and infection: Of note, the aPL epitope specificity is different in COVID (i.e., rarely targeting β2GPI domain I) (24), and the autoantibody persistence over time (≥ 2 positive testing, 12 weeks apart) seems to be absent in most COVID cases (23, 25), in line with what has been described in infection-related cases (26).